Oncotarget is a widely viewed scientific journal that is published weekly. Oncotarget offers a platform for authors to write about oncology, but the additional related subject matter is also allowable, as the topics can be extremely complex.
Oncotarget has been publishing authors manuscripts since 2010 and has been well received. The publication is made available on a weekly basis so that the most recent and relevant information is put forth as soon as possible.
Authors submit their manuscripts to the Editorial Board of Oncotarget, which then reviews the information, and evaluates the merit, the relevancy and the uniqueness of the article to determine if it can be published. The evaluation is done in a peer to peer fashion, meaning that the editors who evaluate are at the same professional level or better than the author. The editors must be experts in the field of topical involvement, and there must be at least two editors involved.
The protocol of very strict because the integrity of the information is very important as the subject matter may eventually be used in a medical procedure on endnote.com, so it must not be invalid as to its proofs and citations. It is very important the focal point of the article be emphasized and validated, as opposed to just opinions and surmised ideas.
There can be no slander, political slant, defamation, sexual, gender or racial bias, ethnic slanting, philosophical or prejudicial bias. The tenor of the manuscript on msubmit.net must be focused on validation of scientific and medical use and procedure. The author should plainly state the purpose and intent of the article at the outset, then proceed to orderly explain how the hypothesis came to be, and then offer citations in original form to prove the procedure or summation.
All information contained in the paper is to be kept in the strictest confidence, and it shall be revealed to no one except the editorial board members who are involved. The content at https://www.researchgate.net/journal/1949-2553_Oncotarget can be discussed with the author, but the theme and content must be kept under wraps until the information is published.
Oncotarget has experienced a positive feedback from the medical and research community due to the timeliness and accuracy of the articles which are published.